These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15900632)

  • 41. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 42. Guideline watch. HIV treatment guidelines updated.
    Zuger A
    AIDS Clin Care; 2006 Jun; 18(6):57. PubMed ID: 16791954
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV and liver disease forum: conference proceedings.
    Sherman KE; Peters M; Koziel MJ
    Hepatology; 2007 Jun; 45(6):1566-77. PubMed ID: 17538932
    [No Abstract]   [Full Text] [Related]  

  • 44. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
    Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
    Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
    Alberti A; Clumeck N; Collins S; Gerlich W; Lundgren J; Palù G; Reiss P; Thiebaut R; Weiland O; Yazdanpanah Y; Zeuzem S;
    J Hepatol; 2005 May; 42(5):615-24. PubMed ID: 15916745
    [No Abstract]   [Full Text] [Related]  

  • 46. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of HIV/HBV coinfection.
    Miller AO
    MedGenMed; 2006 Feb; 8(1):41. PubMed ID: 16915171
    [No Abstract]   [Full Text] [Related]  

  • 48. Highlights in the discovery of antiviral drugs: a personal retrospective.
    De Clercq E
    J Med Chem; 2010 Feb; 53(4):1438-50. PubMed ID: 19860424
    [No Abstract]   [Full Text] [Related]  

  • 49. FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.
    AIDS Read; 2007 Oct; 17(10):478-510. PubMed ID: 17987701
    [No Abstract]   [Full Text] [Related]  

  • 50. Workshop convened on HIV/hepatitis coinfection.
    Núñez M
    IAPAC Mon; 2004 Dec; 10(12):456-60. PubMed ID: 15892200
    [No Abstract]   [Full Text] [Related]  

  • 51. Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
    Aleman J; van den Berk GE; Franssen EJ; de Fijter CW
    AIDS; 2015 Jul; 29(12):1579-80. PubMed ID: 26244398
    [No Abstract]   [Full Text] [Related]  

  • 52. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
    J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005).
    Brook MG; Gilson R; Wilkins E; ;
    HIV Med; 2005 Jul; 6 Suppl 2():84-95. PubMed ID: 16011538
    [No Abstract]   [Full Text] [Related]  

  • 55. Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
    Lê MP; Gervais A; Le Beller C; Long K; Larrouy L; Papy E; Mal H; Descamps D; Peytavin G
    J Antimicrob Chemother; 2013 May; 68(5):1208-9. PubMed ID: 23335198
    [No Abstract]   [Full Text] [Related]  

  • 56. Managing hepatitis B coinfection in HIV-infected patients.
    Peters MG
    Curr HIV/AIDS Rep; 2005 Aug; 2(3):122-6. PubMed ID: 16091258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Report from the 14th Retrovirus Conference. New data on HIV and viral hepatitis coinfection.
    Albrecht H
    AIDS Clin Care; 2007 May; 19(5):41. PubMed ID: 18398990
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    Soriano V; Sheldon J; García-Gasco P; Vispo E
    AIDS; 2007 Oct; 21(16):2253-4. PubMed ID: 18090058
    [No Abstract]   [Full Text] [Related]  

  • 59. Candidates for therapy: HBV.
    Dusheiko G
    J Hepatol; 2006; 44(1 Suppl):S84-9. PubMed ID: 16368159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tenofovir helpful for patients with HBV.
    AIDS Patient Care STDS; 2005 May; 19(5):347. PubMed ID: 15948275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.